Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bicuculline methobromide, a selective GABAA Receptor antagonist with an IC50 value of 3 μM, induces tonic-clonic convulsions in mammals and blocks Ca2+ activated potassium channels. It is applicable in researching epilepsy and related psychiatric disorders.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | 35 days | $ 348.00 |
Description | Bicuculline methobromide, a selective GABAA Receptor antagonist with an IC50 value of 3 μM, induces tonic-clonic convulsions in mammals and blocks Ca2+ activated potassium channels. It is applicable in researching epilepsy and related psychiatric disorders. |
Synonyms | (+)-Bicuculline methobromide, d-Bicuculline methobromide, (+)-Bicuculline methobromide ; d-Bicuculline methobromide |
Molecular Weight | 462.29 |
Formula | C21H20BrNO6 |
CAS No. | 66016-70-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bicuculline methobromide 66016-70-4 (+)-Bicuculline methobromide d-Bicuculline methobromide (+)-Bicuculline methobromide ; d-Bicuculline methobromide inhibitor inhibit